Published in Lancet Neurol on August 07, 2009
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro Oncol (2011) 1.53
The future of high-grade glioma: Where we are and where are we going. Surg Neurol Int (2015) 1.50
Update on molecular findings, management and outcome in low-grade gliomas. Nat Rev Neurol (2010) 1.43
Cognitive functions in primary CNS lymphoma after single or combined modality regimens. Neuro Oncol (2011) 1.25
Review on quality of life issues in patients with primary brain tumors. Oncologist (2010) 1.24
Survival and long-term health and cognitive outcomes after low-grade glioma. Neuro Oncol (2010) 1.22
Neurocognitive function after radiotherapy for paediatric brain tumours. Nat Rev Neurol (2012) 1.19
Value of 11C-methionine PET in imaging brain tumours and metastases. Eur J Nucl Med Mol Imaging (2012) 1.12
Practice changing mature results of RTOG study 9802: another positive PCV trial makes adjuvant chemotherapy part of standard of care in low-grade glioma. Neuro Oncol (2014) 1.07
Regional variation in brain white matter diffusion index changes following chemoradiotherapy: a prospective study using tract-based spatial statistics. PLoS One (2013) 1.03
Voluntary running prevents progressive memory decline and increases adult hippocampal neurogenesis and growth factor expression after whole-brain irradiation. Cancer Res (2010) 1.01
7-Tesla susceptibility-weighted imaging to assess the effects of radiotherapy on normal-appearing brain in patients with glioma. Int J Radiat Oncol Biol Phys (2011) 0.99
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncol (2016) 0.98
A novel nitroxide is an effective brain redox imaging contrast agent and in vivo radioprotector. Free Radic Biol Med (2011) 0.96
Management of low-grade glioma. Curr Neurol Neurosci Rep (2010) 0.96
Cognition and resective surgery for diffuse infiltrative glioma: an overview. J Neurooncol (2012) 0.94
Selective inhibition of microglia-mediated neuroinflammation mitigates radiation-induced cognitive impairment. Radiat Res (2013) 0.94
Factors affecting the cerebral network in brain tumor patients. J Neurooncol (2012) 0.93
Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int J Radiat Oncol Biol Phys (2011) 0.93
Initial treatment patterns over time for anaplastic oligodendroglial tumors. Neuro Oncol (2012) 0.92
Monitoring and optimising cognitive function in cancer patients: Present knowledge and future directions. EJC Suppl (2014) 0.91
Transplantation of human fetal-derived neural stem cells improves cognitive function following cranial irradiation. Cell Transplant (2013) 0.91
Stem cell therapies for the treatment of radiation-induced normal tissue side effects. Antioxid Redox Signal (2014) 0.90
Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment. Acta Neuropathol (2015) 0.90
Radiation techniques for acromegaly. Radiat Oncol (2011) 0.90
Low-grade gliomas. Oncologist (2014) 0.90
Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas. Genome Biol (2014) 0.89
Neuro-oncology: late neurocognitive decline after radiotherapy for low-grade glioma. Nat Rev Neurol (2009) 0.88
Targeted overexpression of mitochondrial catalase prevents radiation-induced cognitive dysfunction. Antioxid Redox Signal (2015) 0.88
New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach. Neuro Oncol (2014) 0.87
Changes in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years. Neuro Oncol (2013) 0.87
Connectivity in MEG resting-state networks increases after resective surgery for low-grade glioma and correlates with improved cognitive performance. Neuroimage Clin (2012) 0.87
Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost. Radiat Oncol (2013) 0.87
Regionally distinct responses of microglia and glial progenitor cells to whole brain irradiation in adult and aging rats. PLoS One (2012) 0.86
Levetiracetam improves verbal memory in high-grade glioma patients. Neuro Oncol (2012) 0.85
Defining the optimal window for cranial transplantation of human induced pluripotent stem cell-derived cells to ameliorate radiation-induced cognitive impairment. Stem Cells Transl Med (2014) 0.85
Low grade gliomas in eloquent locations - implications for surgical strategy, survival and long term quality of life. PLoS One (2012) 0.84
Whole brain radiation-induced cognitive impairment: pathophysiological mechanisms and therapeutic targets. Biomol Ther (Seoul) (2012) 0.84
Health-related quality of life in high-grade glioma patients. Chin J Cancer (2014) 0.84
Neuropsychological functions and quality of life in survived patients with intracranial germ cell tumors after treatment. Neuro Oncol (2013) 0.84
Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide. Neuro Oncol (2017) 0.83
Radiation Therapy Oncology Group 9802: Controversy or Consensus in the Treatment of Newly Diagnosed Low-Grade Glioma? Semin Radiat Oncol (2015) 0.82
Neurocytomas: long-term experience of a single institution. Neuro Oncol (2011) 0.82
Cancer and non-cancer brain and eye effects of chronic low-dose ionizing radiation exposure. BMC Cancer (2012) 0.82
Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma. Cancer (2012) 0.81
Comparison of dose distributions hippocampus in high grade gliomas irradiation with linac-based imrt and volumetric arc therapy: a dosimetric study. Springerplus (2015) 0.81
A Radiation-Induced Hippocampal Vascular Injury Surrogate Marker Predicts Late Neurocognitive Dysfunction. Int J Radiat Oncol Biol Phys (2015) 0.81
Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities. Neuro Oncol (2012) 0.81
Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas. Cochrane Database Syst Rev (2015) 0.81
Long-term outcomes of adjuvant radiotherapy after surgical resection of central neurocytoma. Radiat Oncol (2014) 0.80
Effect of the Maximum Dose on White Matter Fiber Bundles Using Longitudinal Diffusion Tensor Imaging. Int J Radiat Oncol Biol Phys (2016) 0.80
High-grade glioma in elderly patients: can the oncogeriatrician help? Clin Interv Aging (2013) 0.79
A longitudinal, qualitative and quantitative exploration of daily life and need for rehabilitation among patients with high-grade gliomas and their caregivers. BMJ Open (2013) 0.79
Deferred radiotherapy and upfront procarbazine-ACNU-vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade. Onco Targets Ther (2016) 0.78
Management of diffuse low-grade gliomas in adults - use of molecular diagnostics. Nat Rev Neurol (2017) 0.77
Life beyond a diagnosis of glioblastoma: a systematic review of the literature. J Cancer Surviv (2017) 0.77
Acute effects of surgery on emotion and personality of brain tumor patients: surgery impact, histological aspects, and recovery. Neuro Oncol (2015) 0.77
Current treatment of low grade gliomas. Memo (2012) 0.77
Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region. Neuro Oncol (2013) 0.77
Outcomes of pediatric low-grade gliomas treated with radiation therapy: a single-institution study. J Pediatr Hematol Oncol (2014) 0.77
Health related quality of life (HRQOL) in long-term survivors of pediatric low grade gliomas (LGGs). J Neurooncol (2014) 0.77
Cognitive functioning in newly presenting patients with supratentorial intracranial tumors: is there a role for inspection time? Neuro Oncol (2012) 0.77
Neurocognitive challenges in brain tumor survivors: is there anything we can do? J Clin Oncol (2015) 0.77
Indications for Treatment: Is Observation or Chemotherapy Alone a Reasonable Approach in the Management of Low-Grade Gliomas? Semin Radiat Oncol (2015) 0.77
Impaired health-related quality of life in meningioma patients-a systematic review. Neuro Oncol (2017) 0.77
Early-delayed, radiation-induced cognitive deficits in adult rats are heterogeneous and age-dependent. Radiat Res (2014) 0.76
Dynamic hub load predicts cognitive decline after resective neurosurgery. Sci Rep (2017) 0.75
EpiBrainRad: an epidemiologic study of the neurotoxicity induced by radiotherapy in high grade glioma patients. BMC Neurol (2015) 0.75
Reporting of patient-reported health-related quality of life in adults with diffuse low-grade glioma: a systematic review. Neuro Oncol (2016) 0.75
Biomarkers in NOA-04: another piece to the puzzle. Neuro Oncol (2016) 0.75
PCV in low-grade gliomas: benefit from old drugs in an evolving disease entity. Neuro Oncol (2016) 0.75
MR Imaging Evaluation of Intracerebral Hemorrhages and T2 Hyperintense White Matter Lesions Appearing after Radiation Therapy in Adult Patients with Primary Brain Tumors. PLoS One (2015) 0.75
The role of image-guided intensity modulated proton therapy in glioma. Neuro Oncol (2017) 0.75
Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients. Neuro Oncol (2016) 0.75
Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma. Semin Radiat Oncol (2015) 0.75
Hippocampal sparing radiotherapy for glioblastoma patients: a planning study using volumetric modulated arc therapy. Radiat Oncol (2016) 0.75
Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma. Neurooncol Pract (2015) 0.75
Long-Term Cognitive Functioning in Single-Dose Total-Body Gamma-Irradiated Rhesus Monkeys ( Macaca mulatta ). Radiat Res (2016) 0.75
Reducing radiation dose to normal brain through a risk adapted dose reduction protocol for patients with favourable subtype anaplastic glioma. Radiat Oncol (2017) 0.75
Relationship between radiation dose and microbleed formation in patients with malignant glioma. Radiat Oncol (2017) 0.75
Ionizing Radiation-Induced Immune and Inflammatory Reactions in the Brain. Front Immunol (2017) 0.75
Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies. Clin Transl Oncol (2017) 0.75
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat (2009) 7.68
Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA (2002) 5.30
Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res (2004) 4.33
Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med (2008) 4.33
Balloon-assisted coil embolization of intracranial aneurysms: incidence, complications, and angiography results. J Neurosurg (2006) 4.02
Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurol (2012) 3.98
Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2007) 3.65
Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA (2011) 3.40
Graph theoretical analysis of complex networks in the brain. Nonlinear Biomed Phys (2007) 3.20
Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet (2012) 3.14
Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study. Int J Radiat Oncol Biol Phys (2009) 3.13
Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol (2005) 2.71
Cognitive deficits in adult patients with brain tumours. Lancet Neurol (2004) 2.71
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis. Lancet Oncol (2012) 2.64
Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys (2011) 2.54
Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes (2006) 2.48
Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol (2010) 2.46
Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol (2005) 2.42
Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res (2011) 2.42
Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs (2003) 2.35
The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. J Clin Epidemiol (2002) 2.25
Mutant prominin 1 found in patients with macular degeneration disrupts photoreceptor disk morphogenesis in mice. J Clin Invest (2008) 2.24
Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol (2008) 2.23
Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review. Radiother Oncol (2013) 2.21
Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys (2008) 2.13
Whole-brain radiotherapy with simultaneous integrated boost to multiple brain metastases using volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys (2009) 2.03
Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol (2003) 2.00
The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer (2005) 1.97
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res (2013) 1.96
An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer (2008) 1.95
High risk of acute deterioration in patients harboring symptomatic colloid cysts of the third ventricle. J Neurosurg (2002) 1.94
Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques. Radiother Oncol (2010) 1.86
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer (2010) 1.84
Disturbed functional connectivity in brain tumour patients: evaluation by graph analysis of synchronization matrices. Clin Neurophysiol (2006) 1.82
A systematic review of web-based interventions for patient empowerment and physical activity in chronic diseases: relevance for cancer survivors. J Med Internet Res (2013) 1.82
Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. J Thorac Oncol (2011) 1.80
Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study. Neuroradiology (2007) 1.80
The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma. Acta Neuropathol (2010) 1.80
Efficacy of cognitive behavioral therapy and physical exercise in alleviating treatment-induced menopausal symptoms in patients with breast cancer: results of a randomized, controlled, multicenter trial. J Clin Oncol (2012) 1.68
Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors--a meta-analysis. Psychooncology (2011) 1.68
Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer. Int J Radiat Oncol Biol Phys (2005) 1.67
Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer. Int J Radiat Oncol Biol Phys (2004) 1.62
Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach. Eur J Cancer (2007) 1.62
Comparing higher order models for the EORTC QLQ-C30. Qual Life Res (2011) 1.60
Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition. Stroke (2009) 1.57
The course of neurocognitive functioning in high-grade glioma patients. Neuro Oncol (2006) 1.55
Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology. J Clin Epidemiol (2006) 1.55
Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study. Support Care Cancer (2011) 1.52
Health related quality of life in men with prostate cancer. J Urol (2003) 1.51
Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs. Radiother Oncol (2009) 1.49
EORTC QLQ-C15-PAL: the new standard in the assessment of health-related quality of life in advanced cancer? Palliat Med (2006) 1.49
Cost-effectiveness of cognitive behavioral therapy and physical exercise for alleviating treatment-induced menopausal symptoms in breast cancer patients. J Cancer Surviv (2014) 1.49
Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4. Mol Vis (2007) 1.49
Changes in cerebral interstitial glycerol concentration in head-injured patients; correlation with secondary events. Intensive Care Med (2003) 1.48
SMART syndrome: a late reversible complication after radiation therapy for brain tumours. J Neurol (2011) 1.47
Use of health-related quality-of-life assessments in daily clinical oncology nursing practice: a community hospital-based intervention study. Cancer (2008) 1.47
Predictors of outcome in World Federation of Neurologic Surgeons grade V aneurysmal subarachnoid hemorrhage patients. Crit Care Med (2011) 1.44
Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets. Int J Radiat Oncol Biol Phys (2005) 1.43
Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration. Int J Radiat Oncol Biol Phys (2007) 1.43
Systematic review of the diagnostic accuracy of 201Tl single photon emission computed tomography in the detection of recurrent glioma. Nucl Med Commun (2007) 1.41
The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. J Clin Oncol (2006) 1.41
Screening behavior of individuals at high risk for colorectal cancer. Gastroenterology (2005) 1.39
How do brain tumors alter functional connectivity? A magnetoencephalography study. Ann Neurol (2006) 1.38
Impaired survival and long-term neurological problems in benign meningioma. Neuro Oncol (2012) 1.37
Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire. Qual Life Res (2013) 1.33
Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging. Mol Ther (2006) 1.32
Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy? Radiother Oncol (2005) 1.31
Long-term effects of temporal lobe epilepsy on local neural networks: a graph theoretical analysis of corticography recordings. PLoS One (2009) 1.31
Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Radiother Oncol (2011) 1.31
Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapy. Cancer (2010) 1.30
Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy. Cancer Res (2002) 1.30
Late rebleeding of ruptured intracranial aneurysms treated with detachable coils. AJNR Am J Neuroradiol (2005) 1.29
Long-term results following titanium cranioplasty of large skull defects. Neurosurg Focus (2009) 1.28
A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol (2009) 1.28
Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment. Brain (2011) 1.28
Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors. Lung Cancer (2013) 1.27
Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma. J Clin Oncol (2003) 1.26
Volumetric modulated arc radiotherapy for vestibular schwannomas. Int J Radiat Oncol Biol Phys (2009) 1.26